Pin Oak Investment Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3K Hold
70
﹤0.01% 470
2026
Q1
$3K Sell
70
-342
-83% -$16.2K ﹤0.01% 457
2025
Q4
$20K Sell
412
-13
-3% -$665 0.01% 317
2025
Q3
$23.6K Hold
425
0.02% 293
2025
Q2
$29K Sell
425
-14
-3% -$952 0.02% 240
2025
Q1
$29K Hold
439
0.02% 233
2024
Q4
$52K Hold
439
0.05% 181
2024
Q3
$52K Hold
439
0.05% 182
2024
Q2
$63K Sell
439
-37
-8% -$4.9K 0.06% 156
2024
Q1
$61K Sell
476
-75
-14% -$8.93K 0.06% 159
2023
Q4
$57K Buy
551
+25
+5% +$2.47K 0.06% 161
2023
Q3
$48K Buy
526
+456
+651% +$40.2K 0.05% 162
2023
Q2
$6K Buy
+70
New +$5.72K 0.01% 362

Other funds holding NVO

Pin Oak Investment Advisors's NVO Position: Q2 2026 in Review

Pin Oak Investment Advisors held its Novo Nordisk (NVO) position steady in Q2 2026 at 70 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #470.

Pin Oak Investment Advisors first reported a position in NVO in Q2 2023 and has held it in 13 quarters since. The position peaked at $63K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Pin Oak Investment Advisors held 70 shares of Novo Nordisk worth $3K as of Q2 2026.
  • Pin Oak Investment Advisors left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Pin Oak Investment Advisors's portfolio in Q2 2026, its #470 holding.
  • Pin Oak Investment Advisors first reported a position in Novo Nordisk in Q2 2023 and has held it in 13 quarters since.
  • Pin Oak Investment Advisors's Novo Nordisk position peaked at $63K in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Pin Oak Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.